Golsanamlu Zahra, Pashanejad Haniyeh, Rahimpour Elaheh, Jouyban Abolghasem, Farjami Afsaneh, Soleymani Jafar, Ranjbar Fatemeh
Faculty of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, 51666-53431, Iran.
BMC Chem. 2025 May 15;19(1):129. doi: 10.1186/s13065-025-01498-y.
Risperidone (RIS) is one of the most prescribed atypical antipsychotics approved for the treatment of various neuropsychiatric diseases. For the correlation of serum concentration and pharmacological effects of RIS, therapeutic drug monitoring is considered a fundamental concept for clinical application. This paper is provided to develop an electrochemical probe for the determination of RIS in biological samples by modification of glassy carbon electrode (GCE) using gold nanoparticles (AuNPs) and iron metal-organic-frameworks (FeMOFs). This probe fabrication process was characterized with various techniques including Fourier transform infrared (FTIR), emission scanning electron microscopy (FESEM), energy dispersive X-ray (EDX), atomic force microscopy (AFM), and dynamic light scattering (DLS) to confirm the proper synthesis of materials and the sensors designing. The developed probe square-wave voltammetry (SWV) signal was linear upon RIS concentration from 0.02 to 50 µg/mL with a low limit of quantification (LOQ) of 0.02 µg/mL. Based on the validated method, high accuracy and precision, good specificity, and suitable stability of fabricated probes were achieved. As the ultimate step, this method was successfully applied for the quantification of RIS in patients' plasma samples with regular RIS consumption. The fabricated electrochemical demonstrates favorable clinical applicability due to its simplicity, high sensitivity, low sample pretreatment time, and rapid analysis time, making it a promising probe as an alternative to current separation-based methods. Also, the developed probe is cost-effective, as it uses a low amount of materials, decreases sample processing time, and utilizes inexpensive materials, which could remarkably reduce the overall cost of RIS concentration detection in clinical samples. The obtained results showed the potential of the developed probe for fast and reliable detection of RIS in plasma samples.
利培酮(RIS)是最常用的非典型抗精神病药物之一,被批准用于治疗各种神经精神疾病。对于RIS血清浓度与药理作用的相关性,治疗药物监测被认为是临床应用的基本概念。本文旨在通过使用金纳米颗粒(AuNPs)和铁金属有机框架(FeMOFs)修饰玻碳电极(GCE)来开发一种用于测定生物样品中RIS的电化学探针。该探针制备过程通过多种技术进行表征,包括傅里叶变换红外光谱(FTIR)、发射扫描电子显微镜(FESEM)、能量色散X射线(EDX)、原子力显微镜(AFM)和动态光散射(DLS),以确认材料的正确合成和传感器设计。所开发的探针方波伏安法(SWV)信号在RIS浓度为0.02至50μg/mL时呈线性,定量下限(LOQ)低至0.02μg/mL。基于验证的方法,制备的探针具有高精度和精密度、良好的特异性和合适的稳定性。作为最后一步,该方法成功应用于定期服用RIS的患者血浆样品中RIS的定量分析。所制备的电化学探针具有简单、高灵敏度、低样品预处理时间和快速分析时间等优点,具有良好的临床适用性,使其成为当前基于分离方法的有前途的替代探针。此外,所开发的探针具有成本效益,因为它使用少量材料,减少样品处理时间,并使用廉价材料,这可以显著降低临床样品中RIS浓度检测的总成本。获得的结果表明所开发的探针在快速可靠地检测血浆样品中RIS方面具有潜力。